share_log

Nxu Inc | DEFA14A: Others

Nxu Inc | DEFA14A: Others

Nxu Inc | DEFA14A:其他
美股SEC公告 ·  2024/12/27 09:18

Moomoo AI 已提取核心訊息

On December 26, 2024, Nxu Inc. entered into a $3 million private placement agreement with investors, issuing 6.8 million shares of Class A Common Stock and various warrants. The deal includes pre-funded warrants for 5.2 million shares, Series A warrants for 6 million shares, and Series B warrants with a variable share amount.The Series A and B warrants are exercisable upon stockholder approval, with Series A having a $0.50 exercise price subject to potential downward adjustment. The Series B warrants' share amount will be determined based on a reset price calculation. Both warrant series include provisions for cashless exercise and automatic exercise concurrent with Nxu's pending merger with Verde Bioresins, Inc.Nxu also entered into a Registration Rights Agreement to register the resale of the issued securities, and secured voting agreements from key individuals to support the warrant approvals. The company will pay a 7% fee to Maxim Group LLC as the placement agent.
On December 26, 2024, Nxu Inc. entered into a $3 million private placement agreement with investors, issuing 6.8 million shares of Class A Common Stock and various warrants. The deal includes pre-funded warrants for 5.2 million shares, Series A warrants for 6 million shares, and Series B warrants with a variable share amount.The Series A and B warrants are exercisable upon stockholder approval, with Series A having a $0.50 exercise price subject to potential downward adjustment. The Series B warrants' share amount will be determined based on a reset price calculation. Both warrant series include provisions for cashless exercise and automatic exercise concurrent with Nxu's pending merger with Verde Bioresins, Inc.Nxu also entered into a Registration Rights Agreement to register the resale of the issued securities, and secured voting agreements from key individuals to support the warrant approvals. The company will pay a 7% fee to Maxim Group LLC as the placement agent.
2024年12月26日,Nxu Inc. 與投資者簽訂了一項價值300萬的定向增發協議,發行680萬股A類普通股和各種Warrants。該交易包括520萬股的預先融資Warrants,600萬股的A類Warrants,以及具有可變股數的B類Warrants。A類和B類Warrants在股東批准後可行使,A類的行使價格爲0.50美元,可能會進行下調。B類Warrants的股數將基於重置價格的計算來確定。兩個Warrants系列均包含無現金行使和在Nxu與Verde Bioresins, Inc.合併時自動行使的條款。Nxu還與關鍵個人達成了登記權協議,以註冊已發行證券的轉售,並獲取了支持Warrants批准的投票協議。公司將向Maxim Group LLC支付7%的費用作爲承銷代理。
2024年12月26日,Nxu Inc. 與投資者簽訂了一項價值300萬的定向增發協議,發行680萬股A類普通股和各種Warrants。該交易包括520萬股的預先融資Warrants,600萬股的A類Warrants,以及具有可變股數的B類Warrants。A類和B類Warrants在股東批准後可行使,A類的行使價格爲0.50美元,可能會進行下調。B類Warrants的股數將基於重置價格的計算來確定。兩個Warrants系列均包含無現金行使和在Nxu與Verde Bioresins, Inc.合併時自動行使的條款。Nxu還與關鍵個人達成了登記權協議,以註冊已發行證券的轉售,並獲取了支持Warrants批准的投票協議。公司將向Maxim Group LLC支付7%的費用作爲承銷代理。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息